228 related articles for article (PubMed ID: 29709942)
1. Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection.
Matsumoto K; Kikuchi K; Kajiyama Y; Takano Y; Mabuchi M; Doi S; Sato K; Miyakawa H; Yasuda I
Intern Med; 2018 Sep; 57(18):2669-2673. PubMed ID: 29709942
[TBL] [Abstract][Full Text] [Related]
2. A New Treatment for Chronic Hepatitis C.
Aschenbrenner DS
Am J Nurs; 2016 May; 116(5):23. PubMed ID: 27123623
[No Abstract] [Full Text] [Related]
3. Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV.
Cacciato V; Casagrande E; Bodini G; Furnari M; Marabotto E; Grillo F; Giannini EG
Ann Hepatol; 2020; 19(2):222-225. PubMed ID: 32029393
[TBL] [Abstract][Full Text] [Related]
4. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
[TBL] [Abstract][Full Text] [Related]
5. Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antivirals.
López Couceiro L; Gómez Domínguez E; Muñoz Gómez R; Castellano Tortajada G; Ibarrola de Andrés C; Fernández Vázquez I
Rev Esp Enferm Dig; 2019 Feb; 111(2):159-161. PubMed ID: 30449122
[TBL] [Abstract][Full Text] [Related]
6. Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment.
Evon DM; Golin CE; Stewart P; Fried MW; Alston S; Reeve B; Lok AS; Sterling RK; Lim JK; Reau N; Sarkar S; Nelson DR; Reddy KR; Di Bisceglie AM
Contemp Clin Trials; 2017 Jun; 57():58-68. PubMed ID: 28342989
[TBL] [Abstract][Full Text] [Related]
7. Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
De Maria C; Ghidotti I; Grillo F; Giannini EG
Dig Dis Sci; 2019 Feb; 64(2):591-593. PubMed ID: 30386944
[No Abstract] [Full Text] [Related]
8. Drug-induced hepatitis with autoimmune features during minocycline therapy.
Abe M; Furukawa S; Takayama S; Michitaka K; Minami H; Yamamoto K; Horiike N; Onji M
Intern Med; 2003 Jan; 42(1):48-52. PubMed ID: 12583618
[TBL] [Abstract][Full Text] [Related]
9. Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort.
Quaranta MG; Rosato S; Ferrigno L; Amoruso DC; Monti M; Di Stefano P; Filomia R; Biliotti E; Migliorino G; Russo FP; Degasperi E; Chemello L; Brancaccio G; Blanc P; Cannizzaro M; Barbaro F; Morsica G; Licata A; Kondili LA;
Antivir Ther; 2020; 25(2):73-81. PubMed ID: 32242526
[TBL] [Abstract][Full Text] [Related]
10. Resolution of HCV-Autoimmune Hepatitis Overlap Syndrome With Antiviral TreatmentA Paired Liver Biopsy Study.
Putra J; Schiano TD; Fiel MI
Am J Clin Pathol; 2019 Nov; 152(6):735-741. PubMed ID: 31310654
[TBL] [Abstract][Full Text] [Related]
11. Primary biliary cholangitis development after hepatitis C virus eradication with direct acting antivirals: a case report and review of the literature.
Fianchi F; Ponziani FR; Pompili M
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1435-1439. PubMed ID: 32096193
[TBL] [Abstract][Full Text] [Related]
12. The development of type-1 autoimmune hepatitis after chronic hepatitis C (HCV) clearance by direct-acting antivirals (DAA).
Montón C; Escudero MªD; Pascual I
Rev Esp Enferm Dig; 2020 Aug; 112(8):664-665. PubMed ID: 32686431
[TBL] [Abstract][Full Text] [Related]
13. Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4.
Al-Salama ZT; Deeks ED
Drugs; 2017 May; 77(8):911-921. PubMed ID: 28417245
[TBL] [Abstract][Full Text] [Related]
14. Elbasvir/Grazoprevir (Zepatier) for Hepatitis C Virus Infection.
Early J; Maxted G
Am Fam Physician; 2017 Mar; 95(6):393-394. PubMed ID: 28318208
[No Abstract] [Full Text] [Related]
15. [Autoimmune hepatitis and membranous glomerulonephritis under immune therapy in chronic hepatitis C].
Paparoupa M; Huy Ho NA; Schuppert F
Dtsch Med Wochenschr; 2016 May; 141(10):709-11. PubMed ID: 27176065
[TBL] [Abstract][Full Text] [Related]
16. Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir.
Matsumoto K; Kikuchi K; Namura Y; Watanabe A; Tsunashima H; Doi S
Clin J Gastroenterol; 2023 Aug; 16(4):572-579. PubMed ID: 37118643
[TBL] [Abstract][Full Text] [Related]
17. Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis.
Maan R; van Tilborg M; Deterding K; Ramji A; van der Meer AJ; Wong F; Fung S; Sherman M; Manns MP; Cornberg M; Hansen BE; Wedemeyer H; Janssen HL; de Knegt RJ; Feld JJ
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1821-1830.e6. PubMed ID: 27404965
[TBL] [Abstract][Full Text] [Related]
18. Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
Martin MT; Koppe S
Transplantation; 2017 Sep; 101(9):2088-2091. PubMed ID: 28376038
[TBL] [Abstract][Full Text] [Related]
19. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient.
Coriat R; Podevin P
Int J STD AIDS; 2008 Mar; 19(3):208-10. PubMed ID: 18397566
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral and anti-hepatitis C virus direct-acting antiviral-related hepatotoxicity.
Han H; Agarwal R; Martel-Laferriere V; Dieterich DT
Clin Liver Dis; 2013 Nov; 17(4):657-70, ix. PubMed ID: 24099023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
